« Republican Convention - Day 1 | Main | Lamps for HD »
September 01, 2004
Living Cell Technologies
From the news article:
BIOTECH company Living Cell Technologies roared on to the Australian Stock Exchange yesterday 25 per cent above its issue price.
The company is headquartered in Adelaide and raised $6.36 million from investors for more testing of its diabetes, Huntington's disease and haemophilia treatments.
It is developing three products - NeurotrophinCell to treat Huntington's disease, Fac8Cell for haemophilia and DiabeCell for diabetes.
The products use encapsulated cells that are transplanted into the patient and work by replacing and performing the functions of diseased or damaged organs.
Posted by Dave at September 1, 2004 05:57 PM
Trackback Pings
TrackBack URL for this entry:
http://www.huntingtons.info/MT/mt-tb.cgi/565
Comments
Is this Stem Cell research?
Posted by: Fred at September 2, 2004 09:00 AM
No, it is not. It is a method of delivering live cells which does not trigger an auto-immune response.
NeurotrophinCell may (it has not reached human trials yet) be an effective way to help repair damage done to the brain by Huntington's Disease.
Primate trials are set to start late this year.
Posted by: Dave at September 5, 2004 07:59 AM
Post a comment
Thanks for signing in, . Now you can comment. (sign out)
(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)